NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1225296122 MD
Verify on CMS → Lalitha Gudipaty, MD
Endocrinology, Diabetes & Metabolism Physician in Philadelphia, Pennsylvania.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
890
Medicare Part D claims · 266 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
57%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Lalitha Gudipaty, MD filed 890 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in Philadelphia, Pennsylvania, prescribing 57% generic.
- 890
- Part D claims, 2023
- 57%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Lalitha Gudipaty, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
890 Top 27% higher than 73% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Lalitha Gudipaty, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lalitha Gudipaty, MD?
Quality data not reportedPrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
890 66% vs specialty avg
Specialty distribution in Pennsylvania
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Pennsylvania providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Endocrinology, Diabetes & Metabolism Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Lalitha Gudipaty, MD appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding MD credentials at 3400 CIVIC CENTER BLVD, Philadelphia, PA, 19104, with a listed phone of (215) 662-2300. NPI 1225296122 was issued on 05/28/2008.
Medicare Part D records for calendar year 2023 show 890 prescription claims written by this provider, covering 266 Medicare beneficiaries and totaling roughly $199K in drug spend, split 35% brand-name and 57% generic by claim count.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1225296122 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 05/28/2008 |
Hospital and facility affiliations
Facilities where Lalitha Gudipaty, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Kaiser Foundation Health Plan OF The Mid Atlantic States, Inc
Largo, MD
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Pennsylvania PA-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Lalitha Gudipaty, MD. To verify Lalitha Gudipaty, MD's current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases
PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Lalitha Gudipaty, MD - brand share 35.0%
Endocrinology, Diabetes & Metabolism Physician average
35% brand-name claims vs 57% generic, on 890 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
890
Total Claims
$199K
Total Drug Cost
266
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,133
- Total Day Supply
- 63,096
- Brand vs Generic
- 35% brand / 57% generic
- Brand Drug Cost
- $170K
- Generic Drug Cost
- $16K
Patient Demographics
- Average Patient Age
- 71.9 years
- Avg HCC Risk Score
- 1.40
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 37, 65-74: 119, 75-84: 90, 85+: 20
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Lalitha Gudipaty, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
194 claims
- Methimazole
Methimazole
105 claims
- Humalog 66
Humalog
66 claims
- Alendronate Sodium 46
Alendronate Sodium
46 claims
- Hydrocortisone 30
Hydrocortisone
30 claims
- Jardiance 26
Jardiance
26 claims
- Victoza 2-Pak 25
Victoza 2-Pak
25 claims
- Humalog Kwikpen U-… 20
Humalog Kwikpen U-100
20 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 194 |
| Methimazole | 105 |
| Humalog Insulin Lispro | 66 |
| Alendronate Sodium | 46 |
| Hydrocortisone | 30 |
| Jardiance Empagliflozin | 26 |
| Victoza 2-Pak Liraglutide | 25 |
| Humalog Kwikpen U-100 Insulin Lispro | 20 |
| Insulin Glargine-Yfgn | 20 |
| Ozempic Semaglutide | 18 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in PA →
All providers in Pennsylvania →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Lalitha Gudipaty, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Lalitha Gudipaty, MD's 890 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Pennsylvania
Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Gudipaty.
Dr. Munira Abbasi
MD
Pittsburgh, PA
Dr. Jana Abraham
MD
Berwyn, PA
Dr. Rachel Abramczyk
DO
Parkesburg, PA
Dr. Michael Adler
M.D.
Lewisburg, PA
Shivani Agarwal
Philadelphia, PA
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Pennsylvania
Frequently Asked Questions
What is Lalitha Gudipaty, MD's specialty? ▼
Lalitha Gudipaty, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Philadelphia, Pennsylvania. Credentials: MD.
How much does Lalitha Gudipaty, MD prescribe under Medicare Part D? ▼
In 2023, Lalitha Gudipaty, MD wrote 890 Medicare Part D claims totaling $199K in drug costs for 266 beneficiaries.
Where is Lalitha Gudipaty, MD located? ▼
Lalitha Gudipaty, MD is located at 3400 CIVIC CENTER BLVD, Philadelphia, PA, 19104. Phone: (215) 662-2300.
What is Lalitha Gudipaty, MD's NPI number? ▼
Lalitha Gudipaty, MD's National Provider Identifier (NPI) is 1225296122, issued on 05/28/2008.
Does Lalitha Gudipaty, MD prescribe more brand-name or generic drugs? ▼
Lalitha Gudipaty, MD's prescribing is 35% brand-name and 57% generic drugs by claim count, with $170K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Lalitha Gudipaty, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Lalitha Gudipaty, MD's most frequently prescribed drugs include Levothyroxine Sodium, Methimazole, Humalog. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lalitha Gudipaty, MD accept Medicare? ▼
Lalitha Gudipaty, MD appears in CMS Medicare data with 890 Part D claims and 266 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lalitha Gudipaty, MD's credentials? ▼
Lalitha Gudipaty, MD's NPI is 1225296122 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.